Evangelos Terpos to Thalassemia
This is a "connection" page, showing publications Evangelos Terpos has written about Thalassemia.
Connection Strength
1.435
-
Denosumab effects on serum levels of the bone morphogenetic proteins antagonist noggin in patients with transfusion-dependent thalassemia and osteoporosis. Hematology. 2019 Dec; 24(1):318-324.
Score: 0.666
-
Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial. Blood Adv. 2018 11 13; 2(21):2837-2847.
Score: 0.619
-
The role of biphosphonates in the management of thalassemia-induced osteoporosis: a systematic review and meta-analysis. Hormones (Athens). 2018 Jun; 17(2):153-166.
Score: 0.149